163 related articles for article (PubMed ID: 38844583)
1. From real world data to real world evidence to improve outcomes in neuro-ophthalmology.
Colman BD; Zhu Z; Qi Z; van der Walt A
Eye (Lond); 2024 Jun; ():. PubMed ID: 38844583
[TBL] [Abstract][Full Text] [Related]
2. Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process.
Zisis K; Pavi E; Geitona M; Athanasakis K
J Pharm Pharm Sci; 2024; 27():12302. PubMed ID: 38481726
[No Abstract] [Full Text] [Related]
3. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.
Facile R; Muhlbradt EE; Gong M; Li Q; Popat V; Pétavy F; Cornet R; Ruan Y; Koide D; Saito TI; Hume S; Rockhold F; Bao W; Dubman S; Jauregui Wurst B
JMIR Med Inform; 2022 Jan; 10(1):e30363. PubMed ID: 35084343
[TBL] [Abstract][Full Text] [Related]
4. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
Webster J; Smith BD
Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
[TBL] [Abstract][Full Text] [Related]
5. Contemporary Databases in Real-world Studies Regarding the Diverse Health Care Systems of India, Thailand, and Taiwan: Protocol for a Scoping Review.
Shau WY; Setia S; Shinde SP; Santoso H; Furtner D
JMIR Res Protoc; 2022 Dec; 11(12):e43741. PubMed ID: 36512386
[TBL] [Abstract][Full Text] [Related]
6. Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea.
Lee H; Ahn HS; Kwon S; Kang HY; Han E
Clin Transl Sci; 2024 Apr; 17(4):e13801. PubMed ID: 38629484
[TBL] [Abstract][Full Text] [Related]
7. Real-world evidence and product development: Opportunities, challenges and risk mitigation.
Naidoo P; Bouharati C; Rambiritch V; Jose N; Karamchand S; Chilton R; Leisegang R
Wien Klin Wochenschr; 2021 Aug; 133(15-16):840-846. PubMed ID: 33837463
[TBL] [Abstract][Full Text] [Related]
8. Real-World Evidence: A Primer.
Dang A
Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368
[TBL] [Abstract][Full Text] [Related]
9. Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan.
Hiramatsu K; Barrett A; Miyata Y;
Drugs Real World Outcomes; 2021 Dec; 8(4):459-480. PubMed ID: 34148219
[TBL] [Abstract][Full Text] [Related]
10. Data Science Methods for Real-World Evidence Generation in Real-World Data.
Liu F
Annu Rev Biomed Data Sci; 2024 May; ():. PubMed ID: 38748863
[TBL] [Abstract][Full Text] [Related]
11. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
Wu J; Wang C; Toh S; Pisa FE; Bauer L
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
[TBL] [Abstract][Full Text] [Related]
12. Big data and real-world data-based medicine in the management of hypertension.
Okada M
Hypertens Res; 2021 Feb; 44(2):147-153. PubMed ID: 33250517
[TBL] [Abstract][Full Text] [Related]
13. Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.
Morland K; Gerges C; Elwing J; Visovatti SH; Weatherald J; Gillmeyer KR; Sahay S; Mathai SC; Boucly A; Williams PG; Harikrishnan S; Minty EP; Hobohm L; Jose A; Badagliacca R; Lau EMT; Jing ZC; Vanderpool RR; Fauvel C; Leonidas Alves J; Strange G; Pulido T; Qian J; Li M; Mercurio V; Zelt JGE; Moles VM; Cirulis MM; Nikkho SM; Benza RL; Elliott CG
Pulm Circ; 2023 Oct; 13(4):e12317. PubMed ID: 38144948
[TBL] [Abstract][Full Text] [Related]
14. Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements.
Sievers H; Joos A; Hiligsmann M
Int J Technol Assess Health Care; 2021 Feb; 37():e40. PubMed ID: 33622423
[TBL] [Abstract][Full Text] [Related]
15. Clinical Pharmacology Applications of Real-World Data and Real-World Evidence in Drug Development and Approval-An Industry Perspective.
Zhu R; Vora B; Menon S; Younis I; Dwivedi G; Meng Z; Datta-Mannan A; Manchandani P; Nayak S; Tammara BK; Garhyan P; Iqbal S; Dagenais S; Chanu P; Mukherjee A; Ghobadi C;
Clin Pharmacol Ther; 2023 Oct; 114(4):751-767. PubMed ID: 37393555
[TBL] [Abstract][Full Text] [Related]
16. Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement.
Snyder JM; Pawloski JA; Poisson LM
Curr Oncol Rep; 2020 Apr; 22(5):45. PubMed ID: 32297007
[TBL] [Abstract][Full Text] [Related]
17. Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications.
Zou KH; Li JZ; Imperato J; Potkar CN; Sethi N; Edwards J; Ray A
J Multidiscip Healthc; 2020; 13():671-679. PubMed ID: 32801731
[TBL] [Abstract][Full Text] [Related]
18. Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources.
Daien V; Eldem BM; Talks JS; Korobelnik JF; Mitchell P; Finger RP; Sakamoto T; Wong TY; Evuarherhe O; Carter G; Carrasco J
BMC Ophthalmol; 2019 Oct; 19(1):206. PubMed ID: 31619195
[TBL] [Abstract][Full Text] [Related]
19. Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design.
Dagenais S; Russo L; Madsen A; Webster J; Becnel L
Clin Pharmacol Ther; 2022 Jan; 111(1):77-89. PubMed ID: 34839524
[TBL] [Abstract][Full Text] [Related]
20. Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review.
Rogers JR; Lee J; Zhou Z; Cheung YK; Hripcsak G; Weng C
J Am Med Inform Assoc; 2021 Jan; 28(1):144-154. PubMed ID: 33164065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]